Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for influenza in United States

80 results

Sort By:

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Study ID: NCT04772170
Start Date: 2023-10-23
End Date: 2025-06-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement

Study ID: NCT06571747
Start Date: 2024-09-05
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

3750000

Intervention / Treatment

Cardiovascular-Focused Nudge Communication

Sponsor

Kaiser Permanente

Source: clinicaltrials.gov

Share:
Add to list

Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)

Study ID: NCT04080245
Start Date: 2019-11-15
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

18

Intervention / Treatment

Treatment Group Live Attenuated Flu Vaccine (LAIV)

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older

Study ID: NCT06744205
Start Date: 2025-01-06
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

1158

Intervention / Treatment

Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1

TIV mRNA-neurminary (NA)

TIV MRNA-HA VACCINE 2

Quadrivalent Influenza Standard Dose Vaccine

Quadrivalent Influenza Vaccine High Dose

Sponsor

Sanofi Pasteur, a Sanofi Company

Source: clinicaltrials.gov

Share:
Add to list

Commercially Available Cannabis Products for Immune Support

Study ID: NCT05944705
Start Date: 2023-11-01
End Date: 2024-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Immune Support Supplement

Sponsor

Center For Interventional Pain and Spine

Source: clinicaltrials.gov

Share:
Add to list

H5N1 Milk Detection Study

Study ID: NCT06850298
Start Date: 2025-03
End Date: 2025-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Pasteurized milk contaminated with killed A(H5) virus

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

DMID 21-0041; Influenza CVD 59000

Study ID: NCT05666245
Start Date: 2023-02-20
End Date: 2028-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Personal Protective Equipment (PPE) - Under High Air Hygiene

No Intervention - Under High Air Hygiene

Personal Protective Equipment (PPE) - Under Low Air Hygiene

No Intervention - Under Low Air Hygiene

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Symphony IL-6 Study in Patients at Risk of Severe Sepsis

Study ID: NCT05665153
Start Date: 2022-11-22
End Date: 2024-11-21
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment
Sponsor

Bluejay Diagnostics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision

Study ID: NCT06664151
Start Date: 2024-11-26
End Date: 2025-08-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

25

Intervention / Treatment

Fluzone Trivalent

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Community Care Intervention to Decrease COVID-19 Vaccination Inequities

Study ID: NCT06156254
Start Date: 2023-09-21
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment

Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB)

Sponsor

RAND

Source: clinicaltrials.gov

Share:
Add to list